Correlation Between Vera Therapeutics and Oncotelic Therapeutics
Can any of the company-specific risk be diversified away by investing in both Vera Therapeutics and Oncotelic Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vera Therapeutics and Oncotelic Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vera Therapeutics and Oncotelic Therapeutics, you can compare the effects of market volatilities on Vera Therapeutics and Oncotelic Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vera Therapeutics with a short position of Oncotelic Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vera Therapeutics and Oncotelic Therapeutics.
Diversification Opportunities for Vera Therapeutics and Oncotelic Therapeutics
-0.68 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Vera and Oncotelic is -0.68. Overlapping area represents the amount of risk that can be diversified away by holding Vera Therapeutics and Oncotelic Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Oncotelic Therapeutics and Vera Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vera Therapeutics are associated (or correlated) with Oncotelic Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Oncotelic Therapeutics has no effect on the direction of Vera Therapeutics i.e., Vera Therapeutics and Oncotelic Therapeutics go up and down completely randomly.
Pair Corralation between Vera Therapeutics and Oncotelic Therapeutics
Given the investment horizon of 90 days Vera Therapeutics is expected to generate 0.32 times more return on investment than Oncotelic Therapeutics. However, Vera Therapeutics is 3.14 times less risky than Oncotelic Therapeutics. It trades about 0.11 of its potential returns per unit of risk. Oncotelic Therapeutics is currently generating about 0.02 per unit of risk. If you would invest 870.00 in Vera Therapeutics on August 31, 2024 and sell it today you would earn a total of 4,105 from holding Vera Therapeutics or generate 471.84% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 8.56% |
| Values | Daily Returns |
Vera Therapeutics vs. Oncotelic Therapeutics
Performance |
| Timeline |
| Vera Therapeutics |
| Oncotelic Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Vera Therapeutics and Oncotelic Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Vera Therapeutics and Oncotelic Therapeutics
The main advantage of trading using opposite Vera Therapeutics and Oncotelic Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vera Therapeutics position performs unexpectedly, Oncotelic Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Oncotelic Therapeutics will offset losses from the drop in Oncotelic Therapeutics' long position.| Vera Therapeutics vs. Third Harmonic Bio | Vera Therapeutics vs. Cullinan Oncology LLC | Vera Therapeutics vs. Edgewise Therapeutics | Vera Therapeutics vs. Rallybio Corp |
| Oncotelic Therapeutics vs. Processa Pharmaceuticals | Oncotelic Therapeutics vs. Advanced Proteome Therapeutics | Oncotelic Therapeutics vs. Cellectis SA | Oncotelic Therapeutics vs. ChitogenX |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Other Complementary Tools
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |